GlaxoSmithKline put nonprescription drug business up for sale
11/10/2007
GlaxoSmithKline's nonprescription drug unit is said to be under the microscope, as according to reports incoming CEO Andrew Witty is now to decide its fate. Some investors believe that the unit is a drag on the company's stock and profits.